Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Glioma × Minocycline × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

cyclopia sequence 9 Pain 2 Neoplasms, Plasma Cell 2 Multiple Myeloma 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Sleepiness 1 Peripheral Nervous System Diseases 1 Parasomnias 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 Hypesthesia 1 Head and Neck Neoplasms 1 Glioma 1 Fatigue 1 Esophageal Neoplasms 1 Depression 1 Colorectal Neoplasms 1 Anxiety Disorders 1 Anorexia 1 Acute Pain 1

Interventions

Temozolomide 42 Bevacizumab 38 Radiotherapy 16 Magnetic Resonance Spectroscopy 12 Irinotecan 11 Nivolumab 7 Everolimus 6 Radiation 5 Carboplatin 5 poly ICLC 4 pembrolizumab 4 X-Rays 4 Phantoms, Imaging 4 Erlotinib Hydrochloride 4 Carmustine 4 ribociclib 3 fluorodopa F 18 3 Vorinostat 3 Specimen Handling 3 Radiotherapy, Intensity-Modulated 3 Radiosurgery 3 Nuclear Medicine Department, Hospital 3 Modafinil 3 Lomustine 3 trametinib 2 selinexor 2 plerixafor 2 perampanel 2 palbociclib 2 lenvatinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01580969 2019-08-16

RAMBO

University of Utah

Phase 1/2 Completed

22 enrolled 18 charts

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡